|
|
Biogen Inc
MIL •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/10/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization24,620 mln
Float147 mln
Earnings Date07/31/2026
P / E
22.28
Premium valuation
Relative Strength
87
/ 100
Strongly outperforming
Key Fundamentals
EPS7.98
P/E22.28
ROE7.56
RPS57.91
ROIC8.55
ROA4.69
Interest Cover8.38
EBITDA, mln2,278
EV / EBITDA11.85
EV / EBIT16.40
Revenue, mln8,543
EV / Revenue3.16
Financial Strength
Altman Z-Score3.4
Piotroski F-Score
4
/ 9
Beneish M-Score-2.68
Price to Intrinsic Value0.75
Price to Graham Number2.23
Shiller PE Ratio9.55
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
1.79% |
92
/ 100
 |
| 1 Month |
10.55% |
89
/ 100
 |
| 2 Months |
9.55% |
71
/ 100
 |
| 6 Months |
45.01% |
84
/ 100
 |
| 1 Year |
21.29% |
59
/ 100
 |
|
| |
